Products for Research Use Only
RegisterLogin

(Pro3) GIP, human

CAT: 0804-HY-P3584Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P3584Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes[1][2].
CAS Number
299898-52-5
Product Name Alternative
(Pro3) Gastric Inhibitory Peptide, human
UNSPSC
12352209
Target
Insulin Receptor
Type
Peptides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pro3-gip-human.html
Purity
99.79
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](C)C(N1[C@@H](CCC1)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](CCSC)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC4=CNC=N4)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC5=CC=CC=C5)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC6=CNC7=CC=CC=C67)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC8=CNC9=CC=CC=C89)C(N[C@@H](CCCCN)C(N[C@@H](CC%10=CNC=N%10)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC%11=CC=C(C=C%11)O)N
Molecular Formula
C226H338N60O64S
Molecular Weight
4951.53
References & Citations
[1]Victor A Gault, et al. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes. Diabetes. 2005 Aug;54 (8) :2436-46. |[2]A H Sparre-Ulrich, et al. Species-specific action of (Pro3) GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors. Br J Pharmacol. 2016 Jan;173 (1) :27-38.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P1433[Pro3]-GIP (Rat)
HY-P1434-01[Pro3]-GIP (mouse)
HY-P0276-01GIP, human
HY-P0276A-01GIP, human (TFA)
HY-P10972GIP (22-51) human
HY-P74125A-01GIP, Human (HEK293, hFc)
HY-P2542-01GIP (3-42), human
HY-P3247-01[D-Ala2]-GIP (human)
HY-P5390GIP, rat
HY-P10735-01GIP (mouse)

Alternative Products

CatalogName
MBS5818235(Pro3) GIP, human
GTR19150192-01(Pro3) GIP, human acetate
GTR19067668-01(Pro3) Gastric Inhibitory Peptide (GIP), human
M30675[Pro3]-GIP (Rat)
M30674[Pro3]-GIP (Mouse)
MBS5827281[Pro3]-GIP (Mouse) acetate
5838/1[Pro3]-GIP (Mouse) 1 mg
H-7584.1000(Pro3)-Gastric Inhibitory Polypeptide (human)
B5255-.5GIP (human)
MBS826553-01GIP, Human

Popular Products